KRAS and ovarian endometrioid adenocarcinoma: In endometrioid ovarian cancers, homozygous deletion in PTEN was mutually exclusive with KRAS mutation; furthermore, TP53 was frequently mutated in MSS cases (40% of cases), while RPL22 was frequently mutated in MSI [27].